Live Breaking News & Updates on ஆயர்‌ல் ரடுளேஸ்கூ

Stay updated with breaking news from ஆயர்‌ல் ரடுளேஸ்கூ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Researchers discover new way to improve the subcutaneous administration of mRNA


Researchers discover new way to improve the subcutaneous administration of mRNA
If not before, then certainly since the first messenger RNA (mRNA) vaccines to combat the SARS CoV2 virus were approved in Germany, mRNA has become a recognized term even outside scientific circles.
What is less well known is that mRNA can be used to produce much more than just vaccines. Around 50 different procedures for the treatment of diseases including cancer are already being studied in clinical trials.
Scientists from the pharmaceutical company AstraZeneca, with the support of neutron researchers from Forschungszentrum Jülich, have now discovered how the subcutaneous administration of mRNA can be improved. The goal is for chronically ill patients to be able to self-administer the medication on a regular basis. ....

Marianna Yanez Arteta , Yanez Arteta , Heinz Maier Leibnitz Zentrum , Emily Henderson , Centre For Neutron Science , Neutron Science , Aurel Radulescu , Instrument Scientist , Associate Principal Scientist , Advanced Drug Delivery , எமிலி ஹென்டர்சன் , மையம் க்கு நியூட்ரான் அறிவியல் , நியூட்ரான் அறிவியல் , ஆயர்‌ல் ரடுளேஸ்கூ , கருவி விஞ்ஞானி , இணை ப்ரிந்ஸிபல் விஞ்ஞானி ,

Research with Neutrons for Better mRNA Medicines


Date Time
Research with Neutrons for Better mRNA Medicines
Jülich, 3 May 2021. If not before, then certainly since the first messenger RNA (mRNA) vaccines to combat the SARS CoV2 virus were approved in Germany, mRNA has become a recognized term even outside scientific circles. What is less well known is that mRNA can be used to produce much more than just vaccines. Around 50 different procedures for the treatment of diseases including cancer are already being studied in clinical trials. Scientists from the pharmaceutical company AstraZeneca, with the support of neutron researchers from Forschungszentrum Jülich, have now discovered how the subcutaneous administration of mRNA can be improved. The goal is for chronically ill patients to be able to self-administer the medication on a regular basis. ....

United States , Yanez Arteta , Marianna Yanez Arteta , M Yanez Arteta , Heinz Maier Leibnitz Zentrum , Nigel Davies , Centre For Neutron Science , Molecular Therapy , Nucleic Acid , Neutron Science , Aurel Radulescu , Heinz Maier Leibnitz , Wenzel Sch , Associate Principal Scientist , Advanced Drug Delivery , Nucleic Acid Volume , Forschungszentrum Juelich , Anti Inflammatory , Chronic Disease , Clinical Trials , Blood Vessels , Heart Attack , ஒன்றுபட்டது மாநிலங்களில் , நைகல் டேவிஸ் , மையம் க்கு நியூட்ரான் அறிவியல் , மூலக்கூறு சிகிச்சை ,